CREATE MEDIC CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 990 JPY | -0.90% |
|
-1.69% | +10.99% |
| Sales 2022 | 12.26B 79.23M | Sales 2023 | 12.58B 81.35M | Capitalization | 8.12B 52.49M |
|---|---|---|---|---|---|
| Net income 2022 | 460M 2.97M | Net income 2023 | 154M 995K | EV / Sales 2022 | 0.37 x |
| Net cash position 2022 | 3.5B 22.66M | Net cash position 2023 | 3.59B 23.22M | EV / Sales 2023 | 0.36 x |
| P/E ratio 2022 |
17.4
x | P/E ratio 2023 |
52.7
x | Employees | 962 |
| Yield 2022 |
4.2% | Yield 2023 |
4.15% | Free-Float | 60.64% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.90% | ||
| 1 week | -1.69% | ||
| Current month | +2.91% | ||
| 1 month | +2.48% | ||
| 3 months | +11.11% | ||
| 6 months | +8.20% | ||
| Current year | +10.99% |
1 week
987.00
1 018.00
1 month
955.001 039.00
Current year
886.001 039.00
1 year
875.001 039.00
3 years
862.001 132.00
5 years
862.001 149.00
10 years
795.001 488.00
| Managers | Title | Age | Since |
|---|---|---|---|
Masahiro Sato
CHM | Chairman | 64 | 83-11-30 |
Osamu Imazawa
ADM | Chief Administrative Officer | - | - |
Yozo Akaoka
CTO | Chief Tech/Sci/R&D Officer | 62 | 85-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masahiro Sato
CHM | Chairman | 64 | 83-11-30 |
Yozo Akaoka
CTO | Chief Tech/Sci/R&D Officer | 62 | 85-07-31 |
Sumio Ai
BRD | Director/Board Member | 67 | 02-10-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 31 M€ | +7.88% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 20,721 M€ | +11.13% | - | |
| 0.00% | 66,066 M€ | +12.28% | - | |
| 0.00% | 144,586 M€ | +12.12% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 990 | -0.90% | 17,100 |
| 24-04-18 | 999 | +0.50% | 17,600 |
| 24-04-17 | 994 | +0.40% | 19,500 |
| 24-04-16 | 990 | -2.08% | 21,400 |
| 24-04-15 | 1,011 | -0.79% | 17,600 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotes
CREATE MEDIC CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical devices. Its main products include urinary drainage, such as transurethral and nephrostomy; PEG related products; endoscopic products, such as esophagus and stomach; intestinal treatment-devices, such as small intestine and large intestine; anesthesiology products, such as endotracheal tubes and tracheostomy tubes, IVR devices, among others products.
Calendar
2024-05-06
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +10.99% | 58.2M | |
| +17.36% | 28.79B | |
| -37.45% | 2.79B | |
| -10.36% | 2.74B | |
| -3.64% | 1.98B | |
| -2.59% | 1.92B | |
| -14.29% | 1.6B | |
| -8.77% | 1.2B | |
| +14.59% | 1.15B | |
| +1.88% | 1.05B |
- Stock Market
- Equities
- 5187 Stock
